Shareholders meeting

0 Thyrocare Tests you can trust October 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400051 Mumbai- 400001 (SYMBOL: THYROCARE) (SCRIP CODE: 539871) Subject: Declaration of voting results of Postal Ballot along with the report issued by the Scrutinizer as per Regulations 30 and 44(3) read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Ma’am, In reference to our earlier letter dated September 28, 2026 w.r.t. Intimation of Notice of Postal Ballot (‘Notice’) issued to the members of the Company seeking approval of the members on the following matters set out in the Notice, through Postal Ballot by means of remote e-voting only: Sr. Particulars Resolution Type 1. Approval for Purchase of Land and Building from Nueclear Special Resolution Healthcare Limited, a Material Wholly Owned Subsidiary of the Company, pursuant to Regulation 24(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Approval for sale or divestment of Company's investment Special Resolution (in in the entire shareholding of Nueclear Healthcare Limited addition to approval by (“NHL”) a Material Wholly Owned Subsidiary of the way of majority of the Company. public shareholders) The remote e-voting facility was provided to those Members, holding shares as on cut-off date i.e. Friday, September 25, 2026, through Central Depository Services (India) Limited (“CDSL”), the remote e-voting service provider engaged by the Company. The Company’s Registrar and Share Transfer Agent is MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited). The remote e-voting period commenced on Wednesday, September 30, 2026 (09:00 A.M. IST) and ended on Thursday, October 29, 2026 (05:00 P.M. IST). The above-mentioned Resolutions have been duly passed by the Members of the Company with the requisite majority by way of Special Resolutions. The Resolutions are deemed to have been passed on the last date specified for remote e-voting i.e. Thursday, October 29, 2026. We further wish to highlight that Item No. 2, i.e. approval for sale or divestment of the Company’s entire shareholding in Nueclear Healthcare Limited, a material wholly-owned subsidiary, to Trovera Healthcare Private Limited, has, in addition to being passed as a Special Resolution, also been approved by a majority of the public shareholders in terms of Regulation 37A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thyrocare Technologies Limited 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai-400 703, India {g 022-3090 0000 ~ info@thyrocare.com (@ www.thyrocare.com (CIN • L86905MH2000PLC123882) 0 Thyrocare Tests you can trust In this regard, please find enclosed the following disclosures: 1. Voting results in the prescribed format under Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the votes cast by the public shareholders on Item No. 2 for the purposes of Regulation 37A of the said Regulations; and 2. Scrutinizer’s Report dated October 29, 2026 on remote e-voting under Sections 108 and 110 of the Companies Act, 2013 read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014, as amended. The above information will also be made available on the Company's website at www.thyrocare.com (https://investor.thyrocare.com/postal-ballot/) and on the website of Central Depository Services (India) Limited at https://www.evotingindia.com/. We request you to kindly take the above information on your record. Thanking you, Yours faithfully, For Thyrocare Technologies Limited Brijesh Kumar Company Secretary and Compliance Officer Encl: As above Thyrocare Technologies Limited 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai-400 703, India {g 022-3090 0000 ~ info@thyrocare.com (@ www.thyrocare.com (CIN • L86905MH2000PLC123882) Thyrocare Technologies Limited Voting Results of Postal Ballot Notice Dated September 21, 2026 Details of e-voting results as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in respect of the following resolutions: E-voting start date: Wednesday, September 30, 2026 (09:00 A.M. IST) E-voting end date: Thursday, October 29, 2026 (05:00 P.M. IST) Total number of shareholders on Record Date (i.e. Friday, September 25, 76,689 2026 cut-off date for voting) No. of shareholders present in the meeting either in person or through proxy: Promoter and Promoter Group: Not Applicable Public: Not Applicable No. of shareholders attended the meeting through video conferencing Promoter and Promoter Group: Not Applicable Public: Not Applicable Resolution No. 1 Special Resolution: Approval for Purchase of Land and Building from Nueclear Healthcare Limited, a Material Wholly Owned Subsidiary of the Company, pursuant to Regulation 24(6) of the SEBI Resolution required: (Ordinary/ Special) (Listing Obligations and Disclosure Requirements) Regulations, 2015 Whether promoter/ promoter group are interested in the agenda/resolution? Mode of No. of % of Votes Polled No. of No. of % of Votes in % of Votes Voting No. of votes on outstanding Votes – in Votes – favour on votes against on votes shares held polled shares favour Against polled polled E-Voting 81200000 100.0000 81200000 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 81200000 Promoter Group Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 81200000 100.0000 81200000 0 100.0000 0.0000 E-Voting 50807434 90.6430 50807434 0 100.0000 0.0000 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions 56052237 Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 50807434 90.6430 50807434 0 100.0000 0.0000 E-Voting 312758 1.4273 312373 385 99.8769 0.1231 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 21913078 Institutions Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 312758 1.4273 312373 385 99.8769 0.1231 Total 159165315 132320192 83.1338 132319807 385 99.9997 0.0003 Resolution No. 01 has been passed with requisite majority. Resolution No. 2 Special Resolution: Approval for sale or divestment of Company’s investment in the entire shareholding of Nueclear Healthcare Limited (“NHL”), a Material Wholly-Owned Subsidiary of the Resolution required: (Ordinary/ Special) Company Whether promoter/ promoter group are interested in the agenda/resolution? Mode of No. of % of Votes Polled No. of No. of % of Votes in % of Votes Voting No. of votes on outstanding Votes – in Votes – favour on votes against on votes shares held polled shares favour Against polled polled E-Voting 81200000 100.0000 81200000 0 100.0000 0.0000 Promoter and Poll 0 0.0000 0 0 0.0000 0.0000 Promoter 81200000 Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Group Total 81200000 100.0000 81200000 0 100.0000 0.0000 E-Voting 50807434 90.6430 41438829 9368605 81.5606 18.4394 Public Poll 0 0.0000 0 0 0.0000 0.0000 56052237 Institutions Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 50807434 90.6430 41438829 9368605 81.5606 18.4394 E-Voting 312758 1.4273 311360 1398 99.5530 0.4470 Public Non Poll 0 0.0000 0 0 0.0000 0.0000 21913078 Institutions Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 312758 1.4273 311360 1398 99.5530 0.4470 Total 159165315 132320192 83.1338 122950189 9370003 92.9187 7.0813 Resolution No. 02 has been passed with requisite majority. Note: For the purpose of Regulation 37A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the votes cast by the public shareholders in favour of the resolution exceed the votes cast by the public shareholders against the resolution, after excluding the Promoter and Promoter Group and any public shareholder who is a party, directly or indirectly, to the proposed sale, as set out in table of Resolution 2 above. Accordingly, the resolution has been passed as a Special Resolution [Showing first 8,000 characters — download PDF for full document]